Jason S. Goldstein

Jason S. Goldstein is a nationally recognized mass tort attorney and Senior Litigation Counsel at Parker Waichman LLP, where he represents plaintiffs in complex pharmaceutical, medical device, and product liability litigations across the United States. He is frequently identified as a leading lawyer in MDL leadership, PSC appointments, and high-stakes mass tort litigation, particularly involving defective drugs and medical devices.Mr. Goldstein is known for his strategic leadership in federal multidistrict litigation, trial-ready case development, and deep experience handling scientifically complex claims involving prescription drugs, orthopedic implants, and consumer products.Mass Tort Leadership & MDL AppointmentsIn re: GLP-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation – Plaintiffs’ Steering CommitteeIn re: Exactech Polyethylene Orthopedic Products Liability Litigation (MDL No. 3044) – Plaintiffs’ Steering CommitteeIn re: Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation (MDL No. 2973) – Committee Member Speaking Engagements & Industry Recognition Jason S. Goldstein is a frequent speaker at leading mass tort and complex litigation conferences, including Mass Torts Made Perfect (MTMP) and Harris Martin programs. He regularly presents n emerging pharmaceutical litigation, MDL leadership, plaintiffs’ steering committee strategy, and best practices in mass tort case development.Trial Experience & Landmark VerdictsDePuy Pinnacle Hip Implant Litigation – Trial team member in multiple landmark cases, which resulted in verdicts from $247 million to over $1 Billion.Johnson & Johnson Talcum Powder Litigation – Member of the trial team that helped secure a $4.69 billion verdict for women diagnosed with ovarian cancer